Surgery Partners files Form 144 to sell 8,785 shares

Surgery Partners, Inc. disclosure: a Form 144 notice lists 8,785 shares of common stock for sale on 03/06/2026 in connection with equity vesting.

Rhea-AI Filing Summary

Surgery Partners, Inc. disclosure: a Form 144 notice lists 8,785 shares of common stock for sale on 03/06/2026 in connection with equity vesting. The filing shows two vesting entries: 1,738 shares (02/28/2026) and 7,047 shares (03/02/2026).

Insights

Securities Compliance Analyst

Routine Form 144 sale notice tied to equity vesting.

The filing lists 8,785 shares to be sold as reflected on 03/06/2026, with two vesting events: 1,738 shares on 02/28/2026 and 7,047 shares on 03/02/2026. The broker shown is UBS Financial Services Inc.

Cash‑flow treatment and buyer counterparties are not disclosed in the excerpt; subsequent trading activity will depend on holder decisions and market execution methods. Further filings may report completion or settlement details.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the SGRY Form 144 disclose?

It discloses a notice to sell 8,785 shares. The filing dated 03/06/2026 lists two equity vesting entries: 1,738 shares vested on 02/28/2026 and 7,047 shares on 03/02/2026 through equity compensation.

Who is the broker listed on the SGRY Form 144?

The broker is UBS Financial Services Inc. The filing includes broker information showing UBS at 1000 Harbor Blvd, Weehawken, NJ, associated with the sale notice filed on 03/06/2026 for the disclosed shares.

Are the shares in the SGRY filing from compensation or open market holdings?

The shares arise from equity compensation vesting. The excerpt labels both entries as equity vesting / equity compensation, with vesting dates of 02/28/2026 and 03/02/2026, respectively.

Does the Form 144 show proceeds or buyers for SGRY shares?

No proceeds or buyer identities are disclosed in the excerpt. The filing lists quantities and vesting dates but does not state sale prices, proceeds recipients, or counterparties; such details may appear in later settlement disclosures.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/06/2026 - 11:59 AM EST Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001908044
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Surgery Partners, Inc.
SEC File Number	001-37576
Address of Issuer	340 Seven Springs Way, Suite 600 Brentwood TENNESSEE 37027
Phone	(615) 234-5900
Name of Person for Whose Account the Securities are To Be Sold	Marissa Brittenham
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
common	UBS Financial Services Inc 1000 Harbor Blvd 3rd Floor Weehawken NJ 07086	8785	120354.5	129419836	03/06/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
common	02/28/2026	equity vesting	Surgery Partners, Inc.			1738	02/28/2026	equity compensation
common	03/02/2026	equity vesting	Surgery Partners, Inc.			7047	03/02/2026	equity compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	03/06/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/Mijo Suric, for UBS Financial Services Inc, as attorney-in-fact for Marissa Brittenham
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)